Driving Down Lung Cancer Deaths
Screenings, treatment advances and declines in smoking have led to a decrease in lung cancer death rates.
Progress Against Cancer
Screenings, treatment advances and declines in smoking have led to a decrease in lung cancer death rates.
Patients with cancer often have at least one other chronic disease. Researchers hope to shine a light on how conditions and treatments interact in patients with chronic lymphocytic leukemia and other cancer types.
A new nanoscopic biological computer kills cancer cells, spares healthy ones.
Geriatric assessment minimizes toxic effects of treatment for older patients with advanced cancer.
Women who have been diagnosed with breast cancer are at greater risk for developing high blood pressure and diabetes, common risk factors for heart disease.
Researchers find that when treating metastatic melanoma, timing is everything.
Many women are being diagnosed with cervical cancer, despite the availability of tools to prevent and diagnose the disease. Black and Hispanic women and low-income and rural populations are especially vulnerable.
New therapies are being developed to attack a previously untreatable cancer mutation.
Clinical trials rebound after COVID-19 setbacks, and early treatment leads to significant reduction in anal cancer risk among people with HIV.
As outcomes improved for cancer patients in states that expanded Medicaid, disparities in survival disappeared.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn MoreYour donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now